Regístrese
Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Complicaciones y tratamiento
Información de la revista
Vol. 1. Núm. 2.
Páginas 67-70 (Enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 1. Núm. 2.
Páginas 67-70 (Enero 2003)
DOI: 10.1016/S1696-2818(03)71591-1
Acceso a texto completo
Complicaciones y tratamiento
Visitas
11407
Lourdes Román, Adolf Valls
Unidad Neonatal. Departamento de Pediatría. Universidad del País Vasco/E.H.U. Hospital de Cruces. Barakaldo. Bizkaia. España.
Este artículo ha recibido
11407
Visitas
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.J. Martín.
Neonatal surfactant therapy Where do we go?.
J Pediatrics, 118 (1991), pp. 555
[2.]
H.L. Halliday.
Surfactant replacement.
Year Book of Neonatal Medicine 1991, pp. XIV-XXI
[3.]
R.F. Soll, et al.
Natural surfactant extract treatment of RDS.
Neonatal Module of the Cochrane Database of Systematic Reviews. The Cochrane Collaboration, Issue 1,
[4.]
R.F. Soll, F. Blanco.
Natural surfactant extract vs. synthetic surfactant in the treatment of established respiratory distress syndrome.
Systematic Review, Issue 1,
[5.]
H.L. Halliday.
Overview of clinical trials, comparing natural and synthetic surfactants.
Biol Neonate, 67 (1995), pp. 32.ECC
[6.]
R.F. Soll, C.J. Morley, v.s. Prophylactic.
selective use of surfactant in preventing morbidity and mortality in preterm infants.
Systematic Review, Issue 1,
[7.]
J. Egberts, R. Brand, H. Walti, G. Bevilacqua, G. Breart, F. Gardini.
Mortality, severe respiratory distress syndrome and chronic lung disease of newborn are reduced more after prophylactic than after therapeutic administration of surfactant curosurf.
Pediatrics, 100 (1997), pp. E4
[8.]
R.F. Soll.
Surfactant treatment of the very preterm infant.
Biol Neonate, 74 (1998), pp. 35-42
[9.]
Valls i Soler A, Fernández-Ruanova B, López-Heredia y Goya J, Román- Etxebarria L, Rodríguez-Soriano J, Carretero V. A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome. The Spanish Surfactant Collaborative Group. Pediatrics 1998; 101:E4. Disponible en http://www.pediatrics.org/cgi/content/full/101/4/e ECC
[10.]
E.M. Zola, J.H. Gunkel, R.K. Chan, M.O. Lim, I. Knox, B.H. Feldman, et al.
Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome.
J Pediatr, 122 (1993), pp. 453-459
[11.]
T.N. Raju, P. Langenberg.
Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis.
J Pediatr, 123 (1993), pp. 603-610
[12.]
P.B. Pandit, M.S. Dunn, E.A. Colucci.
Surfactant therapy in neonates with respiratory deterioration due to pulmonary haemorrhage.
Pediatrics, 95 (1995), pp. 32-36
[13.]
W.F. Walsh, T.A. Hazinski.
Bronchopulmonary dysplasia.
Intensive Care of the Fetus and Neonate, pp. 642
[14.]
A.R. McPherson.
Retinopathy of Prematurity,
[15.]
G.A. Gregory, J.A. Kitterman, R.H. Phibbs, W.H. Tooley, W.K. Halmilton.
Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure.
N Engl J Med, 284 (1971), pp. 1333-1340
[16.]
R.A. Saunders, A.D. Milner, I.E. Hopkin.
The effect of CPAP on lung mechanics and lung volumes in the neonate.
Biol Neonate, 29 (1976), pp. 178-186
[17.]
M.K. Gittermann, C. Fusch, A.R. Gittermann, B.M. Regazzoni, A.C. Moessinger.
Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infant.
Eur J Pediatr, 156 (1997), pp. 384-388
[18.]
P. Subramanian, D.J. Henderson-Smart, P.G. David.
Prophylactic nasal continuos positive airways pressure for preventing morbidity and mortality in very preterm infants.
Systematic Review, Issue 1,
[19.]
V. Kavvadia, A. Greenough, G. Dimitriou.
Effect on lung function of continuous positive airway pressure administered either by infant flow driver or a single nasal prong.
Eur J Pediatr, 159 (2000), pp. 289-292
[20.]
H. Verder, B. Robertson, G. Greisen, F. Ebbesen, P. Albertsen, K. Lundstrom, et al.
Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome.
N Engl J Med, 331 (1994), pp. 1051-1055
[21.]
J.M. Perlman.
Intraventricular hemorrhage.
Pediatrics, 84 (1989), pp. 913-915
[22.]
M. Amitay, P.C. Etches, N.N. Finer, J.M. Maidens.
Synchronous mechanical ventilation of the neonate with respiratory disease.
Crit Care Med, 21 (1993), pp. 118-124
[23.]
A. Greenough, A.D. Milner, G. Dimitrou.
Syncronized mechanical for respiratory support in newborn infants.
Systematic Review, Issue 1,
[24.]
P. Davis, R. Jankov, L. Doyle, P.H. Henschke.
Randomised, controlled trial of nasal continuous positive airway pressure in the extubation of infants weighing 600-1200 gr.
Arch Dis Child Fetal Neonatal, 79 (1998), pp. F58
[25.]
The HIFO Study Group.
Randomised study of high frequency oscillatory ventilation in infants with severe respiratory distress syndrome.
J Pediatr, 122 (1993), pp. 609
[26.]
F. Morcillo, A. Gutiérrez, I. Izquierdo, J. Pérez, J. Quero, M.D. Elorza, et al.
Ventilación de alta frecuencia como estrategia de rescate en el recién nacido. Estudio multicéntrico español. I..
An Esp Pediatr, 50 (1999), pp. 269
[27.]
W.E. Truog.
High-frequency ventilation vs. conventional ventilation. No winner but no loser.
J Pediatr, 135 (1999), pp. 9-11
[28.]
D.J. Henderson-Smart, T. Bhuta, F. Cools, M. Offringa.
Effective high frequency oscillatory ventilation versus conventional ventilation for acute dysfunction pulmonary in preterm infants.
Systematic Review, Issue 1,
[29.]
F. Cools, M. Offringa.
Neuromuscular paralysis for newborn infants receiving mechanical ventilation.
Systematic Review, Issue 1,
[30.]
J.P. Kinsella, S.R. Neish, E. Shaffer, S.H. Abman.
Lowdose inhalation nitric oxide in persistent pulmonary hypertension of the newborn.
Lancet, 340 (1992), pp. 819-820
[31.]
J.P. Kinsella, S.H. Abman.
Clinical approach to inhaled nitric oxide therapy in newborn with hipoxemia.
J Pediatr, 136 (2000), pp. 717-726
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.